Table 2.
Physiological parameters.
| MAP (mmHg) |
Systolic BP (mmHg) |
CPP (mmHg) |
ICP (mmHg) |
TCD BFV right (cm/s) |
TCD BFV left (cm/s) |
|
|---|---|---|---|---|---|---|
| Day 1 | 86.2 (67.2–111.1) | 122.6 (83.5–181.0) | 76.8 (57.2–97.7) | 7 (1–26) | 51 (20–152) | 54 (23–145) |
| Day 2 | 83.6 (70.3–106.0) | 124.3 (97.5–158.3) | 75.6 (63.9–105.0) | 6.5 (0–26) | 67 (24–140) | 64 (25–138) |
| Day 3 | 84.3 (74.8–115.4) | 128.4 (102.6–162.4) | 77.5 (53.9–122.6) | 8 (0–21) | 76 (46–150) | 74 (34–166) |
| Day 4 | 84.8 (71.6–120.5) | 133.3 (105.3–183.4) | 82.4 (60.6–132.9) | 7 (1–21) | 90 (32–210) | 94 (34–220) |
| Day 5 | 90.7 (66.3–129.1) | 139.2 (109.2–185.6) | 84.2 (60.9–150.8) | 7 (1–30) | 96 (32–210) | 96 (26–200) |
| Day 6 | 92.6 (70.0–135.4) | 144.3 (115.9–182.8) | 88.6 (66.3–129.3) | 7.5 (1–26) | 96 (38–288) | 88 (36–220) |
| Day 7 | 97.0 (71.8–139.1) | 148.9 (108.9–185.5) | 90.2 (66.2–128.4) | 8 (1–21) | 101 (40–178) | 88 (45–236) |
| Day 8 | 99.5 (73.6–132.8) | 150.5 (114.9–189.1) | 90.0 (61.6–128.9) | 7 (2–22) | 94 (23–185) | 99 (34–186) |
| Day 9 | 99.6 (72.4–140.9) | 151.7 (120.4–204.8) | 92.4 (57.7–135.1) | 7 (1–26) | 80 (17–180) | 88 (26–194) |
| Day 10 | 99.4 (72.0–136.9) | 155.1 (117.4–197.3) | 91.1 (21.7–122.2) | 6 (1–57) | 81 (20–200) | 86 (20–194) |
| Day 11 | 99.3 (71.6–131.4) | 150.5 (116.1–198.5) | 90.0 (43.4–126.0) | 7 (1-67) | 88 (26–200) | 86 (28–166) |
| Day 12 | 97.8 (73.0–139.4) | 147.7 (119.1–193.0) | 89.8 (59.4–127.0) | 7 (1–52) | 90 (38–168) | 89 (38–190) |
| Day 13 | 98.5 (74.0–130.4) | 148.5 (106.9–184.6) | 90.7 (55.8–127.6) | 7 (1–22) | 95 (37–180) | 86 (24–180) |
| Day 14 | 97.8 (69.9–131.5) | 146.3 (111.0–192.7) | 87.2 (54.2–119.7) | 7 (1 -39) | 84 (40–210) | 84 (13–190) |
Physiological measurements on each of the 14 monitored study days. Data are presented as median (range).
BFV, blood flow velocity; BP, blood pressure; ICP, intracranial pressure; MAP, mean arterial pressure; TCD, transcranial doppler sonography.